Market Report, "Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2013 Update", Published
Nuclea Biotechnologies Inc. (Nuclea) is a translational medicine company. The company discovers proprietary biomarkers and in-vitro companion diagnostic assays. Its vitro companion diagnostics are used in therapeutic and medical imaging applications such as colon, stomach, leukemia, lung and prostate. Nuclea develops companion diagnostics for other disease indications such as cardiovascular, inflammation, metabolic disorders and neurological. It conducts research on novel molecular oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries. Nuclea is headquartered in Pittsfield, Massachusetts, the US.